L-Arginine Supplementation With or Without Enzyme Inhibitors Treating Erectile Function of Prostate Cancer Survivors
Status:
Completed
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
RATIONALE: L-arginine supplements may improve the quality of life and erectile function in
men who are prostate cancer survivors.
PURPOSE: This randomized phase II trial is studying how well L-arginine supplementation
works with or without enzyme inhibitors in treating erectile function and quality of life of
prostate cancer survivors previously treated with radiation therapy.